{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:48:52Z","timestamp":1791607732710,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01-CA234228"],"award-info":[{"award-number":["P01-CA234228"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR220053"],"award-info":[{"award-number":["RR220053"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008623","name":"Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37-AI064046"],"award-info":[{"award-number":["R37-AI064046"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.09.030","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:03:24Z","timestamp":1790435004000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["APOBEC3 knockout in lentiviral packaging cells improves therapeutic transgene sequence fidelity"],"prefix":"10.1016","author":[{"given":"Annika","family":"Mittelhauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-4240","authenticated-orcid":false,"given":"Alex B.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevyn","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Stefanovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger P.","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-6087","authenticated-orcid":false,"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.030_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v13081526","article-title":"Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.09.030_bib2","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2026.09.030_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.030_bib4","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.030_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene Therapy in a Patient with Sickle Cell Disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.030_bib6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene Therapy in Patients with Transfusion-Dependent beta-Thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.030_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/v13081528","article-title":"Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives","volume":"13","author":"Labb\u00e9","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.09.030_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2009.319","article-title":"Recent advances in lentiviral vector development and applications","volume":"18","author":"M\u00e1trai","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.030_bib9","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.ymthe.2025.05.034","article-title":"Quantifying the mutational landscape of retroviral and lentiviral vectors in gene therapy patients","volume":"33","author":"Hart","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.030_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41467-022-35379-y","article-title":"Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles","volume":"14","author":"Ajoge","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.030_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","article-title":"APOBECs and virus restriction","volume":"479\u2013480","author":"Harris","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.09.030_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-4690-5-51","article-title":"HIV-1 Vif, APOBEC, and intrinsic immunity","volume":"5","author":"Goila-Gaur","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymthe.2026.09.030_bib13","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1073\/pnas.1217399110","article-title":"Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex","volume":"110","author":"Stavrou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.030_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00032-20","article-title":"Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging","volume":"94","author":"Zhao","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.omto.2021.11.012","article-title":"Improved lentiviral vector titers from a multi-gene knockout packaging line","volume":"23","author":"Han","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2026.09.030_bib16","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1128\/JVI.01869-15","article-title":"Release of Vesicular Stomatitis Virus Spike Protein G-Pseudotyped Lentivirus from the Host Cell Is Impaired upon Low-Density Lipoprotein Receptor Overexpression","volume":"89","author":"Otahal","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.stemcr.2020.10.007","article-title":"beta-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production","volume":"16","author":"Han","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2026.09.030_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature11881","article-title":"APOBEC3B is an enzymatic source of mutation in breast cancer","volume":"494","author":"Burns","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.030_bib19","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/nar\/gkq174","article-title":"Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction","volume":"38","author":"Refsland","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.030_bib20","article-title":"APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy","volume":"32","author":"Swanson","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib21","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.05238-11","article-title":"Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1","volume":"85","author":"Hultquist","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002800","article-title":"Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n","volume":"8","author":"Refsland","year":"2012","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.09.030_bib23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/nar\/gkz1164","article-title":"Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure","volume":"48","author":"McDaniel","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.030_bib24","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/JVI.75.16.7252-7265.2001","article-title":"Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA","volume":"75","author":"Khan","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib25","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41467-022-28762-2","article-title":"A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders","volume":"13","author":"Tucci","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.030_bib26","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ymthe.2025.03.058","article-title":"Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy","volume":"33","author":"Williams","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.030_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121952","article-title":"Deleterious and Oncogenic Mutations in the IL7RA","volume":"11","author":"Campos","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2026.09.030_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omtm.2019.11.021","article-title":"Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity","volume":"17","author":"Ferreira","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.09.030_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20051512","article-title":"Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity","volume":"203","author":"Peng","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.09.030_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01985-16","article-title":"Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins","volume":"7","author":"Ahi","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2026.09.030_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/mthe.2000.0123","article-title":"Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer","volume":"2","author":"Sheridan","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.030_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/mt.2013.265","article-title":"Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency","volume":"22","author":"Carbonaro","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.030_bib34","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.09.030_bib35","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal. Chem."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626008002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626008002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:54:29Z","timestamp":1791604469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626008002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S1525001626008002"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.030","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOBEC3 knockout in lentiviral packaging cells improves therapeutic transgene sequence fidelity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}